<!DOCTYPE html>
<html lang="zh-CN">
  <head>
    <link rel="icon" href="/sscc2/images/favicon.ico"><title>休克的局部灌注监测 | 海滨重症</title><meta name="description" content="北戴河医院重症医学科交流平台"><meta charset="utf-8"><meta name="viewport" content="width=device-width,initial-scale=1"><meta name="generator" content="VuePress 2.0.0-beta.10">
    <link rel="preload" href="/sscc2/assets/js/runtime~app.f8337c0a.js" as="script"><link rel="preload" href="/sscc2/assets/css/styles.0ab5c24d.css" as="style"><link rel="preload" href="/sscc2/assets/js/772.b567ef74.js" as="script"><link rel="preload" href="/sscc2/assets/js/app.8bf2b539.js" as="script">
    <link rel="stylesheet" href="/sscc2/assets/css/styles.0ab5c24d.css">
  </head>
  <body>
    <div id="app"><!--[--><div class="theme-container"><header class="navbar"><div class="toggle-sidebar-button"><svg class="icon" xmlns="http://www.w3.org/2000/svg" aria-hidden="true" role="img" viewBox="0 0 448 512"><path fill="currentColor" d="M436 124H12c-6.627 0-12-5.373-12-12V80c0-6.627 5.373-12 12-12h424c6.627 0 12 5.373 12 12v32c0 6.627-5.373 12-12 12zm0 160H12c-6.627 0-12-5.373-12-12v-32c0-6.627 5.373-12 12-12h424c6.627 0 12 5.373 12 12v32c0 6.627-5.373 12-12 12zm0 160H12c-6.627 0-12-5.373-12-12v-32c0-6.627 5.373-12 12-12h424c6.627 0 12 5.373 12 12v32c0 6.627-5.373 12-12 12z" class=""></path></svg></div><span><a href="/sscc2/" class=""><img class="logo" src="https://seasideccm.github.io/img/SSCC.png" alt="海滨重症"><span class="site-name can-hide">海滨重症</span></a></span><div class="navbar-links-wrapper" style=""><!--[--><!--]--><nav class="navbar-links can-hide"><!--[--><div class="navbar-links-item"><a href="/sscc2/bloodflow/" class="nav-link router-link-active" aria-label="血流"><!--[--><!--]--> 血流 <!--[--><!--]--></a></div><div class="navbar-links-item"><div class="dropdown-wrapper"><button class="dropdown-title" type="button" aria-label="指南"><span class="title">指南</span><span class="arrow down"></span></button><button class="mobile-dropdown-title" type="button" aria-label="指南"><span class="title">指南</span><span class="right arrow"></span></button><ul style="display:none;" class="nav-dropdown"><!--[--><li class="dropdown-item"><a href="/sscc2/guidelines/" class="nav-link" aria-label="指南文件夹"><!--[--><!--]--> 指南文件夹 <!--[--><!--]--></a></li><li class="dropdown-item"><a href="/sscc2/guidelines/Cadiovascular/" class="nav-link" aria-label="心血管"><!--[--><!--]--> 心血管 <!--[--><!--]--></a></li><li class="dropdown-item"><a href="/sscc2/guidelines/COVID-19/" class="nav-link" aria-label="新冠肺炎"><!--[--><!--]--> 新冠肺炎 <!--[--><!--]--></a></li><li class="dropdown-item"><a href="/sscc2/guidelines/Respiratory/" class="nav-link" aria-label="呼吸"><!--[--><!--]--> 呼吸 <!--[--><!--]--></a></li><!--]--></ul></div></div><div class="navbar-links-item"><a href="/sscc2/test/" class="nav-link" aria-label="测试"><!--[--><!--]--> 测试 <!--[--><!--]--></a></div><div class="navbar-links-item"><div class="dropdown-wrapper"><button class="dropdown-title" type="button" aria-label="选择语言"><span class="title">选择语言</span><span class="arrow down"></span></button><button class="mobile-dropdown-title" type="button" aria-label="选择语言"><span class="title">选择语言</span><span class="right arrow"></span></button><ul style="display:none;" class="nav-dropdown"><!--[--><li class="dropdown-item"><a aria-current="page" href="/sscc2/bloodflow/Regional%20perfusion%20monitoring%20in%20shock.html" class="router-link-active router-link-exact-active nav-link router-link-active" aria-label="简体中文"><!--[--><!--]--> 简体中文 <!--[--><!--]--></a></li><li class="dropdown-item"><a href="/sscc2/en/bloodflow/Regional%20perfusion%20monitoring%20in%20shock.html" class="nav-link" aria-label="English"><!--[--><!--]--> English <!--[--><!--]--></a></li><!--]--></ul></div></div><div class="navbar-links-item"><a class="nav-link external" href="https://github.com/seasideccm/sscc2" rel="noopener noreferrer" target="_blank" aria-label="sscc"><!--[--><!--]--> sscc <span><svg class="icon outbound" xmlns="http://www.w3.org/2000/svg" ariahidden="true" focusable="false" x="0px" y="0px" viewbox="0 0 100 100" width="15" height="15"><path fill="currentColor" d="M18.8,85.1h56l0,0c2.2,0,4-1.8,4-4v-32h-8v28h-48v-48h28v-8h-32l0,0c-2.2,0-4,1.8-4,4v56C14.8,83.3,16.6,85.1,18.8,85.1z"></path><polygon fill="currentColor" points="45.7,48.7 51.3,54.3 77.2,28.5 77.2,37.2 85.2,37.2 85.2,14.9 62.8,14.9 62.8,22.9 71.5,22.9"></polygon></svg><!--[--><span class="sr-only">open in new window</span><!--]--></span><!--[--><!--]--></a></div><!--]--></nav><!--[--><!--]--><!----></div></header><div class="sidebar-mask"></div><aside class="sidebar"><nav class="navbar-links"><!--[--><div class="navbar-links-item"><a href="/sscc2/bloodflow/" class="nav-link router-link-active" aria-label="血流"><!--[--><!--]--> 血流 <!--[--><!--]--></a></div><div class="navbar-links-item"><div class="dropdown-wrapper"><button class="dropdown-title" type="button" aria-label="指南"><span class="title">指南</span><span class="arrow down"></span></button><button class="mobile-dropdown-title" type="button" aria-label="指南"><span class="title">指南</span><span class="right arrow"></span></button><ul style="display:none;" class="nav-dropdown"><!--[--><li class="dropdown-item"><a href="/sscc2/guidelines/" class="nav-link" aria-label="指南文件夹"><!--[--><!--]--> 指南文件夹 <!--[--><!--]--></a></li><li class="dropdown-item"><a href="/sscc2/guidelines/Cadiovascular/" class="nav-link" aria-label="心血管"><!--[--><!--]--> 心血管 <!--[--><!--]--></a></li><li class="dropdown-item"><a href="/sscc2/guidelines/COVID-19/" class="nav-link" aria-label="新冠肺炎"><!--[--><!--]--> 新冠肺炎 <!--[--><!--]--></a></li><li class="dropdown-item"><a href="/sscc2/guidelines/Respiratory/" class="nav-link" aria-label="呼吸"><!--[--><!--]--> 呼吸 <!--[--><!--]--></a></li><!--]--></ul></div></div><div class="navbar-links-item"><a href="/sscc2/test/" class="nav-link" aria-label="测试"><!--[--><!--]--> 测试 <!--[--><!--]--></a></div><div class="navbar-links-item"><div class="dropdown-wrapper"><button class="dropdown-title" type="button" aria-label="选择语言"><span class="title">选择语言</span><span class="arrow down"></span></button><button class="mobile-dropdown-title" type="button" aria-label="选择语言"><span class="title">选择语言</span><span class="right arrow"></span></button><ul style="display:none;" class="nav-dropdown"><!--[--><li class="dropdown-item"><a aria-current="page" href="/sscc2/bloodflow/Regional%20perfusion%20monitoring%20in%20shock.html" class="router-link-active router-link-exact-active nav-link router-link-active" aria-label="简体中文"><!--[--><!--]--> 简体中文 <!--[--><!--]--></a></li><li class="dropdown-item"><a href="/sscc2/en/bloodflow/Regional%20perfusion%20monitoring%20in%20shock.html" class="nav-link" aria-label="English"><!--[--><!--]--> English <!--[--><!--]--></a></li><!--]--></ul></div></div><div class="navbar-links-item"><a class="nav-link external" href="https://github.com/seasideccm/sscc2" rel="noopener noreferrer" target="_blank" aria-label="sscc"><!--[--><!--]--> sscc <span><svg class="icon outbound" xmlns="http://www.w3.org/2000/svg" ariahidden="true" focusable="false" x="0px" y="0px" viewbox="0 0 100 100" width="15" height="15"><path fill="currentColor" d="M18.8,85.1h56l0,0c2.2,0,4-1.8,4-4v-32h-8v28h-48v-48h28v-8h-32l0,0c-2.2,0-4,1.8-4,4v56C14.8,83.3,16.6,85.1,18.8,85.1z"></path><polygon fill="currentColor" points="45.7,48.7 51.3,54.3 77.2,28.5 77.2,37.2 85.2,37.2 85.2,14.9 62.8,14.9 62.8,22.9 71.5,22.9"></polygon></svg><!--[--><span class="sr-only">open in new window</span><!--]--></span><!--[--><!--]--></a></div><!--]--></nav><!--[--><!--]--><ul class="sidebar-links"><!--[--><!--[--><section class="sidebar-group"><p class="sidebar-heading active">血流</p><ul class=""><li><!--[--><a href="/sscc2/bloodflow/" class="nav-link router-link-active sidebar-link" aria-label="血流理论和技术"><!--[--><!--]--> 血流理论和技术 <!--[--><!--]--></a><!----><!--]--></li><li><!--[--><a href="/sscc2/bloodflow/blood%20flow.html" class="nav-link sidebar-link" aria-label="血流"><!--[--><!--]--> 血流 <!--[--><!--]--></a><!----><!--]--></li><li><!--[--><a aria-current="page" href="/sscc2/bloodflow/Regional%20perfusion%20monitoring%20in%20shock.html" class="router-link-active router-link-exact-active nav-link router-link-active sidebar-link active" aria-label="休克的局部灌注监测"><!--[--><!--]--> 休克的局部灌注监测 <!--[--><!--]--></a><ul class="sidebar-sub-headers"><li><!--[--><a aria-current="page" href="/sscc2/bloodflow/Regional%20perfusion%20monitoring%20in%20shock.html#重点" class="router-link-active router-link-exact-active nav-link sidebar-link" aria-label="重点"><!--[--><!--]--> 重点 <!--[--><!--]--></a><!----><!--]--></li><li><!--[--><a aria-current="page" href="/sscc2/bloodflow/Regional%20perfusion%20monitoring%20in%20shock.html#摘要" class="router-link-active router-link-exact-active nav-link sidebar-link" aria-label="摘要"><!--[--><!--]--> 摘要 <!--[--><!--]--></a><!----><!--]--></li><li><!--[--><a aria-current="page" href="/sscc2/bloodflow/Regional%20perfusion%20monitoring%20in%20shock.html#引言" class="router-link-active router-link-exact-active nav-link sidebar-link" aria-label="引言"><!--[--><!--]--> 引言 <!--[--><!--]--></a><!----><!--]--></li><li><!--[--><a aria-current="page" href="/sscc2/bloodflow/Regional%20perfusion%20monitoring%20in%20shock.html#单一器官灌注评估的局限性。" class="router-link-active router-link-exact-active nav-link sidebar-link" aria-label="单一器官灌注评估的局限性。"><!--[--><!--]--> 单一器官灌注评估的局限性。 <!--[--><!--]--></a><!----><!--]--></li><li><!--[--><a aria-current="page" href="/sscc2/bloodflow/Regional%20perfusion%20monitoring%20in%20shock.html#心脏" class="router-link-active router-link-exact-active nav-link sidebar-link" aria-label="心脏"><!--[--><!--]--> 心脏 <!--[--><!--]--></a><ul class="sidebar-sub-headers"><li><!--[--><a aria-current="page" href="/sscc2/bloodflow/Regional%20perfusion%20monitoring%20in%20shock.html#体格检查" class="router-link-active router-link-exact-active nav-link sidebar-link" aria-label="体格检查"><!--[--><!--]--> 体格检查 <!--[--><!--]--></a><!----><!--]--></li><li><!--[--><a aria-current="page" href="/sscc2/bloodflow/Regional%20perfusion%20monitoring%20in%20shock.html#ecg" class="router-link-active router-link-exact-active nav-link sidebar-link" aria-label="ECG"><!--[--><!--]--> ECG <!--[--><!--]--></a><!----><!--]--></li><li><!--[--><a aria-current="page" href="/sscc2/bloodflow/Regional%20perfusion%20monitoring%20in%20shock.html#心脏超声" class="router-link-active router-link-exact-active nav-link sidebar-link" aria-label="心脏超声"><!--[--><!--]--> 心脏超声 <!--[--><!--]--></a><!----><!--]--></li><li><!--[--><a aria-current="page" href="/sscc2/bloodflow/Regional%20perfusion%20monitoring%20in%20shock.html#contrast-enhanced-sonography" class="router-link-active router-link-exact-active nav-link sidebar-link" aria-label="Contrast-enhanced sonography"><!--[--><!--]--> Contrast-enhanced sonography <!--[--><!--]--></a><!----><!--]--></li></ul><!--]--></li><li><!--[--><a aria-current="page" href="/sscc2/bloodflow/Regional%20perfusion%20monitoring%20in%20shock.html#brain" class="router-link-active router-link-exact-active nav-link sidebar-link" aria-label="BRAIN"><!--[--><!--]--> BRAIN <!--[--><!--]--></a><ul class="sidebar-sub-headers"><li><!--[--><a aria-current="page" href="/sscc2/bloodflow/Regional%20perfusion%20monitoring%20in%20shock.html#体格检查-1" class="router-link-active router-link-exact-active nav-link sidebar-link" aria-label="体格检查"><!--[--><!--]--> 体格检查 <!--[--><!--]--></a><!----><!--]--></li><li><!--[--><a aria-current="page" href="/sscc2/bloodflow/Regional%20perfusion%20monitoring%20in%20shock.html#near-infrared-spectroscopy" class="router-link-active router-link-exact-active nav-link sidebar-link" aria-label="Near-infrared spectroscopy"><!--[--><!--]--> Near-infrared spectroscopy <!--[--><!--]--></a><!----><!--]--></li><li><!--[--><a aria-current="page" href="/sscc2/bloodflow/Regional%20perfusion%20monitoring%20in%20shock.html#transcranial-doppler-sonography" class="router-link-active router-link-exact-active nav-link sidebar-link" aria-label="Transcranial Doppler sonography"><!--[--><!--]--> Transcranial Doppler sonography <!--[--><!--]--></a><!----><!--]--></li></ul><!--]--></li><li><!--[--><a aria-current="page" href="/sscc2/bloodflow/Regional%20perfusion%20monitoring%20in%20shock.html#kidneys" class="router-link-active router-link-exact-active nav-link sidebar-link" aria-label="KIDNEYS"><!--[--><!--]--> KIDNEYS <!--[--><!--]--></a><ul class="sidebar-sub-headers"><li><!--[--><a aria-current="page" href="/sscc2/bloodflow/Regional%20perfusion%20monitoring%20in%20shock.html#physical-signs" class="router-link-active router-link-exact-active nav-link sidebar-link" aria-label="Physical signs"><!--[--><!--]--> Physical signs <!--[--><!--]--></a><!----><!--]--></li><li><!--[--><a aria-current="page" href="/sscc2/bloodflow/Regional%20perfusion%20monitoring%20in%20shock.html#doppler-ultrasound" class="router-link-active router-link-exact-active nav-link sidebar-link" aria-label="Doppler ultrasound"><!--[--><!--]--> Doppler ultrasound <!--[--><!--]--></a><!----><!--]--></li><li><!--[--><a aria-current="page" href="/sscc2/bloodflow/Regional%20perfusion%20monitoring%20in%20shock.html#contrast-enhanced-ultrasound" class="router-link-active router-link-exact-active nav-link sidebar-link" aria-label="Contrast-enhanced ultrasound"><!--[--><!--]--> Contrast-enhanced ultrasound <!--[--><!--]--></a><!----><!--]--></li></ul><!--]--></li><li><!--[--><a aria-current="page" href="/sscc2/bloodflow/Regional%20perfusion%20monitoring%20in%20shock.html#visceral-organs" class="router-link-active router-link-exact-active nav-link sidebar-link" aria-label="VISCERAL ORGANS"><!--[--><!--]--> VISCERAL ORGANS <!--[--><!--]--></a><ul class="sidebar-sub-headers"><li><!--[--><a aria-current="page" href="/sscc2/bloodflow/Regional%20perfusion%20monitoring%20in%20shock.html#physical-signs-1" class="router-link-active router-link-exact-active nav-link sidebar-link" aria-label="Physical signs"><!--[--><!--]--> Physical signs <!--[--><!--]--></a><!----><!--]--></li><li><!--[--><a aria-current="page" href="/sscc2/bloodflow/Regional%20perfusion%20monitoring%20in%20shock.html#doppler-ultrasound-1" class="router-link-active router-link-exact-active nav-link sidebar-link" aria-label="Doppler ultrasound"><!--[--><!--]--> Doppler ultrasound <!--[--><!--]--></a><!----><!--]--></li><li><!--[--><a aria-current="page" href="/sscc2/bloodflow/Regional%20perfusion%20monitoring%20in%20shock.html#contrast-enhanced-ultrasound-1" class="router-link-active router-link-exact-active nav-link sidebar-link" aria-label="Contrast-enhanced ultrasound"><!--[--><!--]--> Contrast-enhanced ultrasound <!--[--><!--]--></a><!----><!--]--></li><li><!--[--><a aria-current="page" href="/sscc2/bloodflow/Regional%20perfusion%20monitoring%20in%20shock.html#indocyanine-green-clearance-and-gastric-tonometry" class="router-link-active router-link-exact-active nav-link sidebar-link" aria-label="Indocyanine green clearance and gastric tonometry"><!--[--><!--]--> Indocyanine green clearance and gastric tonometry <!--[--><!--]--></a><!----><!--]--></li></ul><!--]--></li><li><!--[--><a aria-current="page" href="/sscc2/bloodflow/Regional%20perfusion%20monitoring%20in%20shock.html#conclusion" class="router-link-active router-link-exact-active nav-link sidebar-link" aria-label="CONCLUSION"><!--[--><!--]--> CONCLUSION <!--[--><!--]--></a><!----><!--]--></li></ul><!--]--></li></ul></section><!--]--><!--]--></ul><!--[--><!--]--></aside><main class="page"><!--[--><!--]--><div class="theme-default-content"><!--[--><h1 id="休克的局部灌注监测"><a class="header-anchor" href="#休克的局部灌注监测">#</a> 休克的局部灌注监测</h1><h2 id="重点"><a class="header-anchor" href="#重点">#</a> 重点</h2><p>体格检查技术排除单器官灌注不足的阴性预测价值不错，但诊断的特异性差。 评估心肌灌注的技术方法包括心电图和超声心动图，以及造影增强超声。 近红外光谱和经颅多普勒可用于评估脑灌注和确定大脑的自动调节阈值。 多普勒超声和造影增强超声技术都是评估肾脏和内脏器官灌注的新方法。 大多数技术的一个主要缺点是无法确定器官血流是否足以满足器官的代谢需求。</p><h2 id="摘要"><a class="header-anchor" href="#摘要">#</a> 摘要</h2><p>综述目的：休克患者全身血流得以恢复后，单个器官仍然存在低灌注。在本篇综述中，对休克时单器官灌注监测方法相关文献的结果予以总结。关注在心、脑、肾和/、内脏器官灌注测量方法上。而且只包括那些实时的和床旁的方法。</p><p>最新进展：明确能够评估单个器官灌注的有体格检查技术，心电图，心脏超声，增强超声，近红外光谱和多普勒超声。</p><p>总结：体格检查技术排除单器官第灌注阴性预测价值较好，但诊断的特异性差。间接测量心肌灌注的技术方法包括心电图和超声心动图。超声造影可以量化心肌灌注，但迄今为止仅用于检测局部心肌灌注不足。近红外光谱和经颅多普勒可用于评估脑灌注和确定大脑的自动调节阈值。多普勒超声和造影增强超声技术都是评估肾脏和内脏器官灌注的新方法。大多数技术的一个主要缺点是无法确定器官血流是否足以满足器官的代谢需求。</p><p>关键词：毛细血管再充盈时间、局部灌注、休克、超声</p><h2 id="引言"><a class="header-anchor" href="#引言">#</a> 引言</h2><p>休克是危重病患者常见的疾病，死亡率很高。从病理生理学角度看，休克定义为全身氧供需不匹配，导致细胞缺氧和器官功能障碍[1]。在临床实践中，休克主要是通过体征来诊断的，如外周灌注不足(如双手湿冷，毛细血管再充盈时间延长，桡动脉波动减弱) 、皮肤花斑、出冷汗、神志改变、以及少尿。实验室检查结果(如动脉血乳酸水平、中心静脉/混合静脉血氧饱和度、中心静脉-动脉血二氧化碳分压差、碳酸氢根水平、碱缺失)可进一步帮助临床医生确认休克的诊断[2]。</p><p>休克治疗的关键原则对休克的病因治疗以及稳定血流动力学纠正组织灌注不足予以概括。血流动力学稳定可分为三个步骤(图1)[3] 。第1步结合了紧急恢复冠状动脉和大脑灌注，以防心血管崩溃。这通常意味着(推注)要用血管升压药物，针对只是严重血流动力学不稳定的患者[4]。第2步说的是普遍认可的休克核心治疗，即纠正全身组织低灌注并重建良好的微循环灌注。通过滴定液体、正性肌力药物、血管加压素和少数情况下还有血管扩张药物，使组织缺血的征象和全身低灌注的化验指标得以恢复。</p><p><img src="https://cdn.jsdelivr.net/gh/seasideccm/img/image-20210424211416489.png" alt="image-20210424211416489"></p><p>图1。稳定血流动力学优先原则休克治疗三步法金字塔图示。改编Dünser 等人。[3]。</p><p>休克治疗金字塔的第3步是稳定血流动力学的最后阶段。它适用于全身低灌注已经纠正但某些器官的局部灌注仍然不足的患者 [3]。肾脏、大脑和心脏是最常见的，需要对全身灌注进行特别的调整灌注才能恢复好的器官。原因在于器官的特性，包括自我调节能力邮箱(如肾脏) ，供血动脉狭窄(如心脏) ，或疾病引起的灌注异常(如脑损伤)。然而，主要的难点是如何评估单一器官的灌注。</p><p>本综述对监测休克患者局部组织灌注的方法和技术的文献进行归纳总结。只关注那些实时的和用于床旁的方法。</p><p>检索策略</p><p>文献检索使用 PubMed 数据库进行( https://www.ncbi.nlm.nih.gov//PubMed/)。我们的检索仅限于成人，尽管重点放在近5年出版的手稿上，但不限定出版年份。所用主题语包括: “局部灌注”、“器官灌注”、“肾脏灌注”、“脑灌注”（‘brain perfusion’ 、 ‘cerebral perfusion’）、“心肌灌注”、“冠状动脉灌注”、“肾灌注”（‘renal perfusion’ 、 ‘kidney perfusion’）、“肝脏灌注”、“肠道灌注”、“内脏灌注”和“休克”、“危重病”（‘critical illness’ 、 ‘critically ill’）。此外，主题词还与特定的具体的监测技术术语相结合，例如”超声”、”超声图像”、”多普勒”、”对比增强”、”近红外光谱”、”吲哚青绿清除率”、”胃张力计”。纳入参考文献列表的手稿进一步人工检索是否还有发表的相关文献。</p><h2 id="单一器官灌注评估的局限性。"><a class="header-anchor" href="#单一器官灌注评估的局限性。">#</a> 单一器官灌注评估的局限性。</h2><p>除了少数例外情况，单器官灌注测量技术的局限性最重要的一项在于，不能定量评价血流是否满足器官的代谢需要。当前，只有少数侵入性技术（例如，单器官的静脉置管，在手术中给单个器置入组织探头或近红外光谱探头）可以测量特定器官的代谢或组织氧合判断器官灌注是否充分。虽然实验室参数可以用来诊断缺血引起的器官功能改变，但它们不能用于指导复苏，因为这些参数大多数的反应时间有明显的延迟，显示的器官损伤是已经发生了的。解释这篇综述的结果不能抛开上述局限性。</p><h2 id="心脏"><a class="header-anchor" href="#心脏">#</a> 心脏</h2><h3 id="体格检查"><a class="header-anchor" href="#体格检查">#</a> 体格检查</h3><p>与I型心肌缺血（例如冠状动脉闭塞伴局部心肌缺血）相反，休克相关的心肌灌注不足会导致整个心脏灌注不足，心肌氧供需不匹配（例如II型心肌缺血）[5 &amp;&amp; ]。此型心肌缺血很少引起心绞痛或心脏不适。[6&amp;]体征只能在清醒病人中确定，可能是非特异性的，包括呼吸困难、焦虑、出汗或原因不明的心动过速和低血压 [7]。</p><h3 id="ecg"><a class="header-anchor" href="#ecg">#</a> ECG</h3><p>心电图（ECG）是诊断心肌梗死的基石[8]。心肌缺血发作后数秒（20至24 s）内就会有ST段改变[9]。长时间(&gt; 60min) ST 段改变对一般 ICU 人群的肌钙蛋白升高具有高度特异性(特异性为 95.2%)[10]。监测ECG来发现心肌缺血的主要局限性在于其预测肌钙蛋白升高的敏感性相当低（31.6％）[10]，以及提示心肌缺血的ECG表现在不同的读图人员之间诊断的可靠性只有中等水平[11]。</p><h3 id="心脏超声"><a class="header-anchor" href="#心脏超声">#</a> 心脏超声</h3><p>在缺血导致的局部室壁运动异常的诊断上心脏超声起着至关重要的作用。经皮冠状动脉介入治疗的患者发生冠脉闭塞时，经胸超声心动图在10秒钟内在有心电图ST段改变之前就能诊断出其所引起的局部室壁运动异常[9]。相比之下， II 型心肌缺血时心脏超声对心肌灌注的诊断精度我们知之甚少，只有少数休克患者的数据发表。没有明显冠脉狭窄时，休克所致的心肌灌注不足会引起心室收缩或舒张功能障碍而不是局部室壁运动异常[12&amp;]。尽管心脏超声是诊断重症患者收缩性和舒张性心力衰竭的灵敏方法[13,14]，但这些表现对于心肌灌注不足而言并非是特异性的[15&amp; ,16&amp;]。</p><h3 id="contrast-enhanced-sonography"><a class="header-anchor" href="#contrast-enhanced-sonography">#</a> Contrast-enhanced sonography</h3><p>Contrast-enhanced sonography/ultrasound (CEUS) has been used to assess regional myocardial perfusion and detect coronary artery disease [17]. In 40 ICU patients with elevated troponin levels, CEUS of the myocardium was feasible and could detect regional hypoperfusion and coronary artery disease with a sensitivity of 67% and specificity of 88% [18&amp;]. So far, no data have been published for the use of CEUS to diagnose global myocardial hypoperfusion and type II myocardial ischemia. Limitations of the use of CEUS in the ICU are challenging examination techniques and the need for an experienced operator [17] (Table 1).</p><h2 id="brain"><a class="header-anchor" href="#brain">#</a> BRAIN</h2><h3 id="体格检查-1"><a class="header-anchor" href="#体格检查-1">#</a> 体格检查</h3><p>Physical signs of impaired cerebral perfusion can only be detected in the nonsedated patient. Although an uncompromised mental state is a reliable indicator of adequate cerebral perfusion, a quantitatively or qualitatively altered level of consciousness is nonspecific for cerebral hypoperfusion. However, whenever occurring in a patient with hemodynamic instability, anxiety, agitation, or lethargy should be considered as an indicator of cerebral hypoperfusion until proven otherwise [19]. In rare cases, convulsions or focal deficits (e.g. in patients with stenoses of major cerebral arteries) may be induced by cerebral hypoperfusion [19].</p><h3 id="near-infrared-spectroscopy"><a class="header-anchor" href="#near-infrared-spectroscopy">#</a> Near-infrared spectroscopy</h3><p>NIRS provides real-time transcutaneous measurement of regional tissue oxygenation using optical analysis of reflected near-infrared light [20]. When NIRS optodes are placed over the forehead, emitted photons penetrate the scalp, frontal bone, and frontal lobe of the brain (Fig. 2). Contamination of intracranial tissue oxygen saturation by extracranial tissues is a key limitation of current NIRS techniques [21&amp;]. In addition, as only the superficial cortex is sampled, tissue oxygenation in cerebral structures particularly susceptible to hypoperfusion, such as the grey–white matter interface, basal ganglia, or hippocampi cannot be determined [22]. The tissue oxygen saturation measured by NIRS when applied over the forehead constitutes of 20% arterial, 5% capillary, and 75% venous blood explaining why healthy volunteers breathing room air exhibit values around 70% [23]. In elderly patients before major surgery, average NIRS values of 60% were measured [24]. Absolute values less than 50% or a decrease of the baseline value by greater than 25% are considered potential indicators of brain tissue hypoxia [25]. Although cerebral perfusion is a crucial determinant of tissue oxygen saturation, other factors, such as arterial oxygen saturation, arterial carbon dioxide tension, hemoglobin levels, and regional disorders (e.g. brain injury) influence tissue oxygen saturation [26&amp;&amp;]. Time domain NIRS is a novel technique, which overcomes limitations of current NIRS technologies, such as the lack of brainspecificity and the large variability in quantifying oxygenation [21&amp;].</p><p>In healthy volunteers experiencing simulated hypovolemia by application of lower body negative pressure, changes of cardiac output were correlated both with changes in carotid blood flow and brain tissue oxygen saturation [27&amp;&amp;]. NIRS has been used to indirectly track changes in cerebral blood flow occurring during cardiac, aortic, and carotid artery surgery [28]. Processing of simultaneous changes in the low-frequency signals of NIRS and arterial blood pressure was shown to accurately detect the lower limit of cerebral autoregulation with a sensitivity of 92% and an area under the receiver operator characteristics curve of 0.89 [29]. Using this method, arterial blood pressure excursions below or above brain autoregulation thresholds during cardiac surgery were independently associated with postoperative delirium, acute kidney injury, and mortality [30,31].</p><h3 id="transcranial-doppler-sonography"><a class="header-anchor" href="#transcranial-doppler-sonography">#</a> Transcranial Doppler sonography</h3><p>Using the temporal bone, eye or the foramen magnum as windows, pulsed wave TCD can be used to determine blood flow velocities in the arteries of the circle of Willis [32]. As flow velocities in cerebral arteries depend on both blood flow and vascular diameter, mean blood flow velocities are correlated with but not equal to cerebral blood flow. Therefore, no absolute values of blood flow velocities can accurately indicate the onset of cerebral hypoperfusion. Relative reductions by 60–80% have been proposed as threshold values for cerebral hypoperfusion [33,34]. In 20 healthy volunteers, changes in middle cerebral artery flow assessed by TCD were correlated with changes in perfusion assessed by gadoliniumenhanced MRI [35]. In 30 healthy volunteers, blood flow velocity and cerebrovascular conductance measured in the middle cerebral artery with colourcoded TCD correlated with hippocampus and occipitoparietal blood flow as measured by arterial spinlabelled perfusion MRI [36].</p><p>A systematic review evaluated the use of TCD to assess cerebral perfusion and autoregulation in patients with sepsis or septic shock [37,38]. In 36 heart failure patients, TCD was used to assess cerebral perfusion during intra-aortic balloon pump (IABP) therapy. The velocity time integral measured in the middle cerebral artery increased during IABP augmentation suggesting that cerebral perfusion is increased by IAPB use [39]. In 37 patients on venoarterial ECMO therapy, TCD measurements revealed that mean flow velocities were higher and pulsatility indices lower in patients cannulated over the axillary artery compared with femoral arterial cannulation [40&amp;]. Comparable with NIRS, TCD has been used in combination with arterial blood pressure to determine cerebral autoregulation thresholds in critically ill patients and during cardiac or vascular surgery [41&amp;&amp;].</p><h2 id="kidneys"><a class="header-anchor" href="#kidneys">#</a> KIDNEYS</h2><h3 id="physical-signs"><a class="header-anchor" href="#physical-signs">#</a> Physical signs</h3><p>Urine output has long been considered the key physical sign to assess renal perfusion in patients with shock. It has been recognized as a valid predictor of kidney failure and included in the definitions of acute kidney injury [42,43]. However, the view on urine output as an indirect marker of renal perfusion has recently become more granular. Although adequate urine output (&gt;0.3 to 0.5 ml/kg/h [44,45]) can generally be considered an indicator of adequate renal blood flow, other causes of oliguria than kidney hypoperfusion have been identified [46]. First, in patients with shock, the neurohumoral stress response leads to reduced glomerular filtration, increased sodium, and water retention resulting in oliguria despite adequate renal blood flow. Second, alterations of intra-renal blood flow, such as changes in preglomerular and postglomerular resistances as well as increased intrarenal shunting can decrease glomerular filtration rate despite preserved or increased renal perfusion, particularly in sepsis patients. Third, glomerular and more commonly tubular damage (e.g. because of ischemia, inflammation, mitochondrial dysfunction, or cell cycle arrest) induce oliguria in critically ill patients. Finally, it has been recognized that not only decreased arterial blood flow results in renal hypoperfusion but also venous congestion because of elevated central venous pressures (e.g. in hypervolemia or heart failure). Taking these points into consideration, oliguria may only be an indicator of renal hypoperfusion during the early phases of shock [46]. Accordingly, a multicentric feasibility trial found that a restrictive fluid strategy targeting, among other endpoints, urine output only during the first 2 h after randomization resulted in improved kidney function compared with standard care in septic shock patients. [47]. A prospective, observational study including 30 patients in early septic shock reported that capillary refill time and skin mottling were correlated with the renal pulsatility index, a Doppler sonographic marker of renal vascular tone. Changes in the extent of skin mottling during the first 72 h after study inclusion were associated with changes in the renal pulsatility index [48].</p><h3 id="doppler-ultrasound"><a class="header-anchor" href="#doppler-ultrasound">#</a> Doppler ultrasound</h3><p>Comparable to TCD, (colour-aided) Doppler ultrasound has been used to noninvasively determine renal blood flow velocities at the bedside. Using quotients of systolic, diastolic, and mean blood flow velocities, the renal resistive and renal pulsatility index can be calculated. Both parameters accurately reflect renal vascular tone and allow estimation of renal perfusion [49]. Side-to-side differences, interrater variability, and feasibility of these measurements in the ICU were favourable [50–52]. Measurements in healthy volunteers suggested reference values for the renal resistive index of 0.6–0.7. An increase greater than 0.7 reflects renal vasoconstriction and was associated with reduced renal perfusion [49]. In patients with septic shock, the renal resistive index was higher in patients developing acute renal failure than in those who did not [50]. Similar observations were made in severe sepsis, multiple trauma, and unselected critically ill patients [53,54]. In both of the latter studies, a renal resistive index of 0.71 was identified as the cut-off value with the highest value to predict subsequent development of acute kidney injury. Similarly, a renal resistive index greater than 0.7 predicted progression of hemodynamically stable multiple trauma patients to hemorrhagic shock by detecting occult hemorrhage-related hypoperfusion [55].</p><p>Furthermore, Doppler ultrasound has been used to track renal hemodynamic effects of fluid loading in patients with circulatory failure [56]. Given its close relationship to renal blood flow and arterial blood pressure, the renal resistive index has been used to determine the mean arterial pressure target at which renal perfusion was optimized. In septic shock patients, a norepinephrine-induced increase in mean arterial blood pressure from 65–75 mmHg resulted in a decrease in the renal resistive index and an increase in urine output [57].</p><p>Doppler measurements of intrarenal venous blood flow reflect venous drainage of the kidneys. Accordingly, a discontinuous venous outflow of the kidney was found to be an indicator of renal congestion in heart failure patients. In these patients, intrarenal venous flow patterns were associated with right atrial pressures (e.g. continuous flow pattern: 5.4  2.5 mmHg; biphasic pattern: 9.5  3.5 mmHg; monophasic pattern: 14.9  4.3 mmHg; P &lt; 0.001) [58]. In 145 ICU patients after cardiac surgery, a portal vein pulsatility index greater than 50% was independently associated with a greater degree of systemic venous congestion and a higher incidence of postoperative acute kidney injury [59]. These data suggest that the technically less demanding Doppler measurement of portal venous flow could be used as a surrogate marker of impaired renal vein drainage.</p><h3 id="contrast-enhanced-ultrasound"><a class="header-anchor" href="#contrast-enhanced-ultrasound">#</a> Contrast-enhanced ultrasound</h3><p>Assessment of renal blood flow by CEUS was closely correlated with measurements of renal plasma flow as determined by the para-aminohippuric acid technique [60,61] (Table 1). Feasibility and excellent inter-observer reliability (r 2 ¼ 0.92) were reported for the use of CEUS in the ICU [62,63]. In a controlled, prospective study, CEUS was used to compare cortical renal perfusion between septic shock patients and ICU patients without septic shock. The perfusion index of the renal cortex was lower and the mean transit time higher in septic shock patients. Furthermore, the mean transit time measured in the renal cortex was higher in septic shock patients with severe acute kidney injury compared with those without [64]. Similarly, a decrease in the renal perfusion index by 50% was identified using CEUS measurements in 11 cardiac surgical patients on the first postoperative day compared with baseline values suggesting that renal perfusion is significantly reduced during the first 24 postoperative hours [62].</p><p>CEUS has been used to evaluate the effects of catecholamine agents on renal perfusion. A dopamine infusion at 2mg/kg/min increased renal cortical blood flow measured by CEUS in healthy volunteers [61]. In a prospective cohort study, CEUS was used to evaluate changes in renal perfusion before and after a norepinephrine-induced increase in mean arterial pressure from 60–65 to 80– 85 mmHg. Although the mean perfusion index did not change before and after the increase in blood pressure, a wide variability in the response of the perfusion index to increased norepinephrine doses was observed (-51 to +97% compared with baseline) [63].</p><h2 id="visceral-organs"><a class="header-anchor" href="#visceral-organs">#</a> VISCERAL ORGANS</h2><h3 id="physical-signs-1"><a class="header-anchor" href="#physical-signs-1">#</a> Physical signs</h3><p>There are no physical signs allowing examination of hepatic or splenic perfusion in patients with shock. Although the absence of gut sounds is an unspecific sign of hepatosplanchnic hypoperfusion, presence of physiologic gut sounds is an indicator of adequate gastrointestinal perfusion [65]. Capillary refill time in early septic shock directly correlated with the Doppler ultrasound-derived pulsatility index of the liver and intestines indicating that a prolonged capillary refill time in early septic shock might be a marker of hepatic and intestinal vasoconstriction [48].</p><h3 id="doppler-ultrasound-1"><a class="header-anchor" href="#doppler-ultrasound-1">#</a> Doppler ultrasound</h3><p>Although Doppler ultrasound of the liver is a well recognized method to assess liver perfusion [66], we failed to identify studies on its use to evaluate liver perfusion in shock. A case series on the use of portal vein Doppler ultrasound in six patients with shock suggested that absent or significantly reduced hepatic venous blood flow in the presence of normal or increased pulmonary venous flow can indicate severely impaired venous return [67].</p><p>The splenic resistive index assessed by Doppler ultrasound measurements was an independent predictor of hemorrhagic shock development within the first 24 h from admission in hemodynamically stable multiple trauma patients [68]. Changes in the splenic resistive index in response to volume loading mirrored cardiac responsiveness and systemic hemodynamics in mechanically ventilated patients following cardiac surgery. A greater than 9% reduction of the splenic resistive index was a marker of fluid-induced increase in stroke volume with 100% specificity and 100% positive predictive value. A greater than 4% reduction in the splenic resistive index was always associated with an improvement in splanchnic perfusion as indicated by an increase in lactate clearance and a reduction in systemic vascular resistance regardless of changes in stroke volume [69].</p><h3 id="contrast-enhanced-ultrasound-1"><a class="header-anchor" href="#contrast-enhanced-ultrasound-1">#</a> Contrast-enhanced ultrasound</h3><p>CEUS has been introduced as a promising method to assess intestinal perfusion in critically ill patients. So far, most studies have been published on its use to detect intestinal ischemia in patients with suspected bowel ischemia. In these patients, the sensitivity and specificity of a diminished or absent CEUS signal was 85 and 100%, respectively [70–72]. Furthermore, CEUS could detect shock-related splenic hypoperfusion [73] and hepatic artery or portal vein flow alterations in liver transplant recipients [74,75] (Table 1).</p><table><thead><tr><th>Table 1. Factbox contrast-enhanced ultrasound</th></tr></thead><tbody><tr><td>Enables real-time visualization of organ blood flow</td></tr><tr><td>Superior to colour Doppler ultrasound as it detects slower flow in smaller vessels</td></tr><tr><td>Uses specific sonographic contrast agents (e.g. gas filled microbubbles), which oscillate under the influence of ultrasound waves</td></tr><tr><td>Assessment of organ/tissue perfusion can be done subjectively or objectively using time–intensity curves in specific regions of interest</td></tr><tr><td>Commonly used quantitative measures of tissue perfusion are time to peak, peak intensity, area under the curve, and mean transit time.</td></tr><tr><td>Specific imaging techniques and software are required to perform CEUS [e.g. low mechanical index (&lt;0.2) imaging]</td></tr><tr><td>Shares the same limitations as other ultrasound techniques</td></tr><tr><td>Examination techniques challenging, thus requiring experienced operators</td></tr></tbody></table><h3 id="indocyanine-green-clearance-and-gastric-tonometry"><a class="header-anchor" href="#indocyanine-green-clearance-and-gastric-tonometry">#</a> Indocyanine green clearance and gastric tonometry</h3><p>Both Indocyanine green (ICG) clearance and gastric tonometry have been used to evaluate hepatic and gastric perfusion in critically ill patients [77–80]. However, both methods suffer from significant limitations and are not routinely used in clinical practice. No study evaluating its use to monitor hepatic or gastrointestinal perfusion in patients with shock has been published for the last 5 years.</p><h2 id="conclusion"><a class="header-anchor" href="#conclusion">#</a> CONCLUSION</h2><p>Despite of restoration of adequate systemic blood flow in patients with shock, single organs may remain hypoperfused. Physical examination techniques have a reasonable negative predictive value to exclude single organ hypoperfusion, but are nonspecific to detect it. 间接测量心肌灌注的技术方法包括心电图和超声心动图。CEUS can quantify myocardial perfusion but has so far only been used to detect regional myocardial hypoperfusion. NIRS and TDS can be used to assess cerebral perfusion and determine autoregulation thresholds of the brain. Both Doppler and CEUS techniques are novel methods to evaluate renal and visceral organ perfusion. 大多数技术的一个主要缺点是无法确定器官血流是否足以满足器官的代谢需求。</p><!--]--></div><footer class="page-meta"><!----><!----><!----></footer><nav class="page-nav"><p class="inner"><span class="prev"> ← <a href="/sscc2/bloodflow/blood%20flow.html" class="nav-link" aria-label="血流"><!--[--><!--]--> 血流 <!--[--><!--]--></a></span><!----></p></nav><!--[--><!--]--></main></div><!----><!--]--></div>
    <script src="/sscc2/assets/js/runtime~app.f8337c0a.js" defer></script><script src="/sscc2/assets/js/772.b567ef74.js" defer></script><script src="/sscc2/assets/js/app.8bf2b539.js" defer></script>
  </body>
</html>
